# YELLOW WAX

URL: https://app.greenveil.ai/ingredients/ingredient_unii_2_za36_h0_s2_v
Categories: pharma
Identifier: cfr:21 CFR 184.1973

> YELLOW WAX. Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 40 mg Assessed from 11 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 40 mg

## Regulatory status

- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 80.67 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 3.22 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 213.7 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 0.1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 0.01 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 5 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 20 %w/w
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.

_Assessed by Greenveil._